Antibodies in serum of convalescent patients following mild COVID-19 do not always prevent virus-receptor binding

  • Pia Gattinger
  • , Kristina Borochova
  • , Yulia Dorofeeva
  • , Rainer Henning
  • , Renata Kiss
  • , Bernhard Kratzer
  • , Bernhard Mühl
  • , Thomas Perkmann
  • , Doris Trapin
  • , Martina Trella
  • , Paul Ettel
  • , Inna Tulaeva
  • , Winfried F Pickl
  • , Rudolf Valenta

Research output: Journal article (peer-reviewed)Letter/short communication

Original languageEnglish
Pages (from-to)878-883
Number of pages6
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume76
Issue number3
DOIs
Publication statusPublished - Mar 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adolescent
  • Adult
  • Aged
  • Angiotensin-Converting Enzyme 2/metabolism
  • Antibodies, Viral/blood
  • Binding Sites
  • COVID-19/diagnosis
  • Convalescence
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Immunoglobulin G/blood
  • Immunoglobulin M/blood
  • Male
  • Middle Aged
  • Receptors, Coronavirus/metabolism
  • SARS-CoV-2/immunology
  • Young Adult

Cite this